Company Name: Beigene, Ltd.

Beigene, Ltd. is a biopharmaceutical company. The company is engaged in the development of molecularly targeted and immuno-oncology therapeutics designed to treat cancer.   

Ticker Symbol: BGNE (NASDAQ)

Company Website: www.beigene.com

Social Media: Beigene LinkedIn

Headquarters: Beijing, China; registered offices in Cayman Islands